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A b s t r a c t  
Cytotoxic, antioxidative burst and antileishmanial properties of leaf extract and fractions of Setaria 
megaphylla were investigated to ascertain the folkloric claims of its potency in inflammatory 
diseases and infections. The leaf extract and fractions of Setaria megaphylla were investigated for 
anticancer activity against HeLa cells using SRB method and DNA interaction activity using gel 
electrophoresis. Antioxidative burst activity of the extract in whole blood, neutrophils and 
macrophages was also investigated using luminol/lucigenin-based chemiluminescence assay. The 
extract and fractions were similarly screened for antileishmanial activity against promastigotes of 
Leishmania major in vitro. The GCMS analysis of the most active fraction against HeLa cells was 
carried out. The leaf extract was found to exert significant anticancer activity with the hexane fraction 
exhibiting the most pronounced effect. The crude extract and the fractions did not interact with DNA 
when investigated using electrophoresis. The extract prominently inhibited oxidative burst activity in 
whole blood, isolated polymorphonuclear cells (PMNs) and mononuclear cells (MNCs) when two 
different phagocytosis activators (serum opsonizing zymosan-A and PMA) were used. The extract 
also exhibited moderate antileishmanial activity against promastigotes of Leishmania major in vitro. 
GCMS analysis of active fraction revealed pharmacologically active compounds. These results 
suggest that the leaf extract/fractions of S. megaphylla possesses cytotoxic, antioxidative burst and 
antileishmanial activities and these justify its use in ethnomedicine to treat inflammatory diseases 
and microbial infections and can be exploited in primary healthcare. 




Setaria megaphylla (Steud) Dur & Schinz (Poaceae) also called 
broad leafed brittle grass is a tall, robust, tufted, perennial grass 
used mainly as pasture grass. It occurs in tropical and subtropical 
areas of Africa, America and India where there is high rainfall [1,2] 
(Van Oudtshoorn, 1999, Lowe, 1989). The plant is use traditionally 
by the Ibibios in Akwa Ibom State, Nigeria in the treatment of 
various ailments such as malaria, inflammation and diabetes. The 
plant has also been reported to possess antiplasmodial activity in 
vitro [3] and in vivo [4]. The leaf extract as reported by Okokon and 
Antia [5]contains flavonoid, carbohydrate, terpenes, saponins, 
tannins, anthraquinones and cardiac glycosides with LD50 of 2.4 ± 
0.5g/kg.  Hypoglycaemic and antidiabetic activities have been 
reported of the leaf and root extracts of this plant [4,6]. The 
antiiflammatory and antinociceptive activities of the ethanolic leaf 
extract of Setaria megaphylla have also been reported by Okokon 
et al.[7]. Considering the ethnomedical records of this plant in 
herbal medicine and the few reported biological activities, we 
undertook to investigate the cytotoxic, immunomodulatory and 
antileishmanial teffect of this leaf extract and fractions as well as 
GCMS analysis of hexane fraction which had not been evaluated 
previously to reveal the phytochemical components of leaf extract 
of S. megaphylla to provide information on medicinal potentials of 
this plant. 
Materials and methods 
Plants collection 
The plant material Setaria megaphylla (leaf) were collected in 
compounds in Uruan area, Akwa Ibom State, Nigeria in April, 2011. 
The plant was identified and authenticated by Dr. Magaret Bassey 
of Department of Botany and Ecological Studies, University of Uyo, 
Uyo, Nigeria.     
Extraction 
The leaves were washed and shade-dried for two weeks. The dried 
plants’ materials were further chopped into small pieces and 
reduced to powder. The powdered material was macerated in 70% 
ethanol. The liquid filtrates were concentrated and evaporated to 
dryness in vacuo 40°C using rotary evaporator. The crude 
ethanolic extract (100g) was further partitioned successively into 1L 
each of n-hexane, dichloromethane, ethyl acetate and butanol to 
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The ethanolic crude extract was screened for cellular antioxidant 
activities in whole blood, neutrophils and macrophages using 
chemiluminescence assay. Briefly, Luminol or lucigenin-enhanced 
chemiluminescence assay were performed as described previously 
[8,9]. Briefly, 25µL diluted whole blood (1:50 dilution in sterile 
HBSS++) or 25µL of PMNCs (1×106) or MNCs (5×106) cells were 
incubated with 25µL of serially diluted plant extract with 
concentration ranges between 6.25 and 100 µg/mL. Control wells 
received HBSS++ and cells but no extract. Tests were performed 
in white 96 wells plates, which were incubated at 37 ◦C for 30 min 
in the thermostated chamber of the luminometer. Opsonized 
zymosan-A or PMA 25µL, followed by 25µL luminol (7×105M) or 
lucigenin (0.5mM) along with HBSS++ was added to each well to 
obtain a 200µL volume/well. The luminometer results were 
monitored as chemiluminescence RLU with peak and total integral 
values set with repeated scans at 30 s intervals and 1 s points 
measuring time. 
Cytotoxic activity  
The growth inhibitory and cytotoxic activities of the ethanolic 
extracts and fractions were evaluated against HeLa cells (Cervix 
cancer cell) by using the sulforhodamine-B assay [10]. The cells 
(10000 cells/100 µL) in 96-well plate were incubated for 24 h at 37 
°C in a humidified 5% CO2 incubator. The stock solutions of 
ethanolic extract, fractions were prepared in DMSO. Various 
dilutions of the ethanolic extracts and fractions (0.1, 1, 10, 100, and 
250 µg/mL), were added (100 µL) in each well. After 48 h of 
incubation, 50 µL of cold TCA (50%) was added gently and left for 
30 min at room temperature, followed by washing with distilled 
water and drying overnight. To each well, 100 µL of SRB solution 
(0.4% wt/vol in 1% acetic acid) was added and after 10 min, the 
unbound stain was removed by washing with acetic acid (1%), and 
air-dried at room temperature. The protein bound stain was 
solubilized with tris base (pH 10.2), and was shaken for 5 min. 
Absorbance was measured at 515 nm using a microplate reader. 
The absorbance of the appropriate blanks, including test substance 
blank, and control (without drug), was used to calculate the growth 
inhibition, and cytotoxicity of the test compounds, and represented 
as GI50, TGI and LC50 (µg/mL) values. 
 GI50 = Concentration of the drug causing 50% growth inhibition of 
the cells 
TGI = Concentration of the drug causing total growth inhibition of 
the cells 
LC50 = Lethal concentration of the drug that killed 50% of the cells 
 
DNA interaction studies using gel electrophoresis  
DNA protection assay was performed according to the protocol of 
Tian and Hua [11]. The reaction was carried out in an Eppendorf 
tube at the total volume of 15 μl containing 0.5 μg of pBR322 DNA 
in 3μl of 50 mM phosphate buffer (pH 7.4), and 5 μl of tested 
samples (DCM fraction) at concentrations 0.1, 0.5, 1.0, 10, 50 and 
100    μg/ml and standard drug, paclitaxel, 20 µg/mL. Then, the 
mixture was incubated at 37°C for 1 h. The mixture was subjected 
to 1% agarose gel electrophoresis. DNA bands (open circular, 
supercoiled and linear) were stained with ethidium bromide and 
were analyzed qualitatively by scanning with Doc-IT computer 
program (VWR).  
Antileishmanial activity 
The antileishmanial activity of the extracts and fractions were 
evaluated against promastigotes of Leishmania major (DESTO) in 
culture using microplates. Leishmania major promastigotes were 
grown in bulk, early in modified NNN biphasic medium, using 
normal physiological saline. Then the promastigotes were cultured 
with RPMI 1640 medium supplemented with 10% heat inactivated 
fetal bovine serum (FBS). The parasites (Leishmania major) were 
harvested at log phase and centrifuged at 3000 rpm for 10 min. 
They were washed three times with saline at same speed and time. 
Finally the parasites were counted with the help of Neubauer 
chamber under the microscope and diluted with fresh culture 
medium to give a final density of 106cells/ml. In a 96-well micro titer 
plate, 180 ml of the culture medium was added in different wells.  
The extracts and fractions were dissolved in PBS (Phospate 
buffered saline, pH 7.4 containing 0.5% MeOH, 0,5% DMSO) to 
make a stock concentration of 1000 mg/ml.  20 µl of each 
extract/fraction concentration was added to the wells and serially 
diluted to get working concentrations ranging between 1.0 to 100 
µg/ml. 100 ml of parasite culture (final density of 106cells/ml) was 
added in all wells. Two rows were left, one for negative and other 
for positive control. Negative controls received the medium while 
the positive controls received Pentamidine and amphotericin B as 
standard antileishmanial compounds. The plate was incubated 
between 21-22°C for 72 h. The culture was examined 
microscopically for cell viability by counting the number of motile 
cells on an improved Neubauer counting chamber and IC50 values 
of compounds possessing antileishmanial activity were calculated 
[12]. 
Gas chromatography-Mass spectrometry analysis 
 Quantitative and qualitative data were determined by GC and GC-
MS, respectively. The fraction was injected onto a Shimadzu GC-
17A system, equipped with an AOC-20i autosampler and a split/ 
splitless injector. The column used was an DB-5 (Optima-5), 30 m, 
0.25 mm i.d., 0.25 µm df, coated with 5 % diphenyl-95 % 
polydimethylsiloxane, operated with the following oven temperature 
programme: 50 °C, held for 1 min, rising at 3 °C/min to 250 °C, held 
for 5 min, rising at 2 °C/min to 280 °C, held for 3 min; injection 
temperature and volume, 250 °C and 1.0 µl, respectively; injection 
mode, split; split ratio, 30:1; carrier gas, nitrogen at 30 cm/s linear 
velocity and inlet pressure 99.8 KPa; detector temperature, 280 °C; 
hydrogen, flow rate, 50 ml/min; air flow rate, 400 ml/min; make-up 
(H2/air), flow rate, 50 ml/min; sampling rate, 40 ms. Data were 
acquired by means of GC solution software (Shimadzu). Agilent 
6890N GC was interfaced with a VG Analytical 70-250s double -
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focusing mass spectrometer. Helium was used as the carrier gas. 
The MS operating conditions were: ionization voltage 70 eV, ion 
source 250 0C. The GC was fitted with a 30 m x 0.32 mm fused 
capillary silica column coated with DB-5. The GC operating 
parameters were identical with those of GC analysis described 
above. 
Identification of the compounds  
The identification of components present in the various active 
fractions of the plants’ extracts was based on direct comparison of 
the retention times and mass spectral data with those for standard 
compounds, and by computer matching with the Wiley and Nist 
Libraries, as well as by comparison of the fragmentation patterns of 
the mass spectra with those reported in the literatures [13,14]. 
Results 
 Anticancer activity against HeLa cells.  
The results of cytotoxic activity of crude extract and fractions of 
Setaria megaphylla shows significant activity with the hexane 
fraction exerting highest activity than other fractions and crude 
extract (Table 1). The potency order was hexane> 
dichloromethane> ethyl acetate>butanol> acqueous> crude 
extract. 
 




GI50(µg/ml) LC50(µg/ml) TGI(µg/ml) 
Crude extract 165.0±3.21 244.2±0.52 231.3±3.16 
hexane fraction 28.8±0.57 71.3±1.32 44.3±1.41 
DCM fraction 37.2±0.56 77.3±1.84 60.3±1.45 
Ethyl acetate fraction 40.0±1.15 83.6±1.20 60.6±1.22 
Butanol 41.2±0.57 83.3±1.17 46.0±1.38 
Aqueous fraction  38.3±1.15 93.5±0.18 65.0±1.18 
Doxorubucin(µM) 0.61±0.03µM 7.80±0.80µM 3.60±0.30µM 
Data are represented as mean ± SEM of three independent experiments 
Values in the table are concentrations of extract/fraction expressed as µg/ml 
GI50 = Concentration of the drug causing 50% growth inhibition of the cells 
TGI = Concentration of the drug causing total growth inhibition of the cells 
LC50 = Lethal concentration of the drug that killed 50% of the cells 
 
DNA interaction activity 
Gel electrophoresis results shows that treatment of E. coli DNA 
with various concentrations of the hexane fraction of Setaria 
megaphylla did not produce any effect on the DNA. Similar effect 
was also observed with the standard drug used, paclitaxel. (Figure 
1).  
Antileishmanial activity.  
Crude extract and fractions of ethanolic leaf extract of Setaria 
megaphylla exerted significant antileishmanial activity when tested 
against promastigotes of Leishmania major. Ethyl acetate fraction 
exerted a higher activity than other fractions and crude extract 
though uncomparable to the standard drugs, pentamidine and 
amphotericin B (Table 3). 
Cellular antioxidant activity.  
 Ethanolic leaf extract of Setaria megaphylla was observed to 
exhibit pro-oxidant effect at lower doses and antioxidant effect at  
 
Figure 1: The effect of various concentrations of hexane fraction of 
Setaria megaphylla on DNA interraction using gel electrophoresis. 
 
higher doses especially in the whole blood, while different degrees 
of inhibitory effect on the oxidative burst activities in neutrophils 
   CTR  0.1  0.5  1.0   10   50  100  STD 
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and macrophages was also recorded and were in dose-dependent 
manner.  The extract produced -5.80 – 53.70 % inhibition in whole 
blood, 0.00 – 69.50 % in neutrophils when activated with zymosan-
A, 49.70 – 80.40 % in neutrophils when activated with PMA and -
15.70 – 54.10 % in macrophages (Table 2). 
GC-MS analysis  
The GCMS analysis of the hexane fraction of Setaria megaphylla 
revealed the presence of 21 bioactive compounds with major and 
minor ones as represented in Table 4.  
Discussion 
Setaria megaphylla is use traditionally in the treatment of various 
ailments and disease especially inflammatory diseases. In this 
study, the leaf which has been reported to possess some 
pharmacological properties have been found in this study to exert 
pronounced cytotoxic activity against HeLa cells with the hexane  
 
Table 2: Cellular antioxidant activity of ethanolic leaf extract of Setaria megaphylla 
 
CELL TYPE Concentration(µg/ml) %INHIBITION(RLU) 
WHOLE BLOOD 
1 -5.80 ± 1.04 




0.5 0.00± 0.00 
5 17.50 ± 2.68 
50 69.50 ±1.32 
NEUTROPHILS 
(extracellular) 
0.5 49.70 ± 8.90 
5 64.90 ± 2.25 
50 80.40 ± 2.54 
MACROPHAGES 
0.5 -15.70 ± 5.43 
5 -11.60 ±6.01 
50 54.10 ± 1.73 
Data are represented as mean ± SEM of three independent experiments 
 




Crude extract 73.40±0.75 
Hexane fraction >100 
DCM fraction >100 
Ethyl acetate fraction 84.23±0.34 
Butanol  fraction >100 
Aqueous fraction  >100 
Pentamidine 5.09±0.04 
Amphotericin B 0.29±0.05 






fraction having the highest  activity, immunomodulatory as well as 
moderate antileishmanial activity.  The cytotoxic mechanism of 
action was found to be unrelated to DNA interaction and is likely to 
involve interference with cell division processes. However, the 
GCMS analysis revealed the presence of some pharmacologically 
active compounds such as phytol, Hexadecanoic acid methyl ester, 
9,12,15-octadecatrienoic acid ethyl ester (Z,Z,Z)-, 8,11,14- 
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Table 4 : GC –MS  analysis  of  hexane fraction of Setaria megaphylla 
 
S/No. NAME OF COMPOUND  RI MOL.WT CHEMICAL 
FORMULA 
1. 2,4,6-trimethyl octane 311 156 C11H24 
2. O-decyl hydroxylamine 376 173 C19H23NO 
3 2,6,8-trimethyl decane 439 184 C13H28 
4. 3-methyl undecane 498 170 C12H26 
5. 6,10,14-trimethyl-2-pentadecanone 580 268 C18H36O 
6 Hexadecanoic acid 658 256 C16H32O2 
7. 2-methyl, Hexadecanoic methyl ester 659 284 C18H36O2 
8. Phytol 717 296 C20H40O 
9. 9,12-octadecadienoyl chloride (Z,Z) 739 298 C18H31ClO 
10. Hexadecatrienoic acid methyl ester 743 264 C17H28O2 
11. Hexadecanoic acid methyl ester 755 284 C18H36O2 





13. 8,11,14-eicosatrienoic acid (Z,Z,Z) 805 306 C20H34O2 
14 Phthalic acid,diisooctyl ester 907 390 C24H38O4 
15. Vitamin E 1225 430 C29H50O2 
16. -Elemene 1340 204 C15H24 
17 Urs-12-ene 1498 410 C30H50 
18 Bicyclogermacrene 1501 204 C15H24 
19 α-muurolene 1504 204 C15H24 
20 Germacrene- A 1505 204 C15H24 
21 Guaiol 1595 222 C15H26O 
     
 
 
eicosatrienoic acid (Z,Z,Z), Vitamin E and mono and sequiterpenes 
such as -Elemene, Bicyclogermacrene, α-muurolene, Germacrene- 
A which have been implicated in the anticancer activity of plants 
[15,16]. Some phyto-components with compound nature of 
flavonoids found in this extract such as palmitic acid (hexadecanoic 
acid,ester and n-hexadecaonoic acid), unsaturated fatty acid and 
linolenic (docosatetraenoic acid and octadecatrienoic acid) are 
reported by Kumar et al.,[17] to have as antimicrobial, anti-
inflammatory, antioxidant, hypocholesterolemic, cancer preventive, 
hepatoprotective, antiarthritic, antihistimic, antieczemic and 
anticoronary properties.  Moreso, Omega-3-fatty acids have been 
found to be essential for normal growth and development and may 
play an important role in the prevention and treatment of coronary 
artery disease, hypertension, diabetes, and arthritis, other 
inflammatory and auto immune disorders and cancer [18, 19, 20]. 
These compounds and others are likely to be involved in the 
cytotoxic activity of this extract. 
The leaf extract was also observed to exhibit significant 
antioxidative burst activity in whole blood, neutrophils (extracellular 
and intracellular) and macrophages. This activity may have 
resulted from the presence of fatty acids, phytol and other  
 
 
monoterpenes and sesquiterpenes as revealed by GCMS analysis. 
These compounds have been reported to possess antioxidant 
activity [17, 21]. Although no compound was isolated in this study, 
these compounds present in the seed and leaf of Setaria 
megaphylla are likely to be present in the leaf extract thereby 
contributing to the significant antioxidant activity observed. The 
significant antioxidant activity of this extract explains the prominent 
anticancer activity of the leaf extract. Generation of reactive oxygen 
species has been implicated in the pathogenesis of cancer and 
other diseases [22]. The activities of antioxidant counteract the 
redox state precipitated intracellularly and hence ensure 
cytotoxicity. This could possibly be one of the mechanisms of 
anticancer activity of this extract. 
The leaf extract also demonstrated moderate antileishmanial 
activity. Antimicrobial activities are known to be promoted by 
proxidant state. In this study, lower doses of the extract have been 
observed to exhibit pro-oxidant activity. This activity has been 
reported to enhance antimicrobial activity [23] and may have 
contributed to the antileishmanial activity observed in this study. 
Compounds such as terpenes (mono and sesquiterpenes) as well 
as palmitic acid, hexadecanoic acid, hexadecanoic acid ethyl ester, 
and linoleic acid which have been found to be present in the root 
extract have been reported to possess antimicrobial activity [17, 
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24]. These compounds may have been responsible for the 
antileishmanial activity observed in this study. 
Conclusion 
From the results of these studies, it can be concluded that the stem 
bark extract of Setaria megaphylla has cytotoxic activity against 
HeLa cells, immunomodulatory and antileishmanial activities which 
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